Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout

ClinicalTrials.gov ID: NCT00985127

Public ClinicalTrials.gov record NCT00985127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 12:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Dose-Ranging, Two-Part, Multi-Center Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study will be conducted in two parts. The first is a parallel-group design, evaluating doses of 40 mg, 80 mg or 120 mg BCX-4208. The second part is planned as a dose-escalation study, evaluating higher doses including 160 mg, 240 mg and 320 mg BCX-4208. The study's primary endpoint is the change in uric acid in the blood compared to baseline measurement prior to treatment, assessed on Day 22.

Study identification

NCT ID
NCT00985127
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
BioCryst Pharmaceuticals
Industry
Enrollment
99 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 69 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2009 (Type not available)
Primary completion
Sep 2010 (Actual)
Completion
Sep 2010 (Actual)
Last update posted
Jan 23, 2012

2009 – 2010

United States locations

U.S. sites
24
U.S. states
21
U.S. cities
24
Facility City State ZIP Site status
Radiant Research, Inc. Scottsdale Arizona 85251 —
Catalina Pointe Clinical Research Tucson Arizona 85704 —
Irvine Center for Clinical Research Irvine California 92618 —
San Diego Arthritis Medical Clinic San Diego California 92108 —
Avail Clinical Research DeLand Florida 32720 —
Anchor Research Center Naples Florida 34102 —
East-West Medical Research Institute Honolulu Hawaii 96814 —
Selah Medical Center Boise Idaho 83704 —
Kentucky Medical Research Center Lexington Kentucky 40504 —
Arthritis & Osteoporosis Center of Maryland Frederick Maryland 21702 —
Olive Branch Family Medical Center Olive Branch Mississippi 38654 —
Medex Healthcare Research St Louis Missouri 63117 —
Bozeman Urgent Care Center Bozeman Montana 59715 —
Heartland Clinical Research Omaha Nebraska 68134 —
Arthritis Center of Reno Reno Nevada 89502 —
New Mexico Clinical Research & Osteoporosis Center Albuquerque New Mexico 87106 —
Triangle Medical Research Associates Raleigh North Carolina 27609 —
STAT Research Dayton Ohio 45417 —
Lynn Health Science Institute Oklahoma City Oklahoma 73112 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Carolinas Center for Rheumatology & Arthritis Rock Hill South Carolina 29732 —
Health Concepts Rapid City South Dakota 57702 —
Renaissance Clinical Research Dallas Texas 75235 —
Northwest Clinical Research Center Bellevue Washington 98004 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00985127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 23, 2012 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00985127 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →